B. Kaplan, K. Meyers, and S. Schulman, The pathogenesis and treatment of hemolytic uremic syndrome, J Am Soc Nephrol, vol.9, issue.6, pp.1126-1133, 1998.

H. Tsai and E. Lian, Antibodies to von Willebrand Factor???Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura, New England Journal of Medicine, vol.339, issue.22, pp.1585-1594, 1998.
DOI : 10.1056/NEJM199811263392203

M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P. Kyrle et al., willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome, N Engl J Med, issue.22, pp.3391578-1584, 1998.

V. Fremeaux-bacchi, F. Fakhouri, L. Roumenina, M. Dragon-durey, and C. Loirat, Syndrome h??molytique et ur??mique li?? ?? des anomalies du compl??ment, La Revue de M??decine Interne, vol.32, issue.4, pp.232-240, 2011.
DOI : 10.1016/j.revmed.2009.09.039

M. Noris and G. Remuzzi, Atypical Hemolytic???Uremic Syndrome, New England Journal of Medicine, vol.361, issue.17, pp.1676-1687, 2009.
DOI : 10.1056/NEJMra0902814

R. Saunders, C. Abarrategui-garrido, V. Fremeaux-bacchi, E. Goicoechea-de-jorge, T. Goodship et al., The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models, Human Mutation, vol.346, issue.3, pp.222-234, 2007.
DOI : 10.1002/humu.20435

V. Fremeaux-bacchi, E. Moulton, D. Kavanagh, M. Dragon-durey, J. Blouin et al., Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome, Journal of the American Society of Nephrology, vol.17, issue.7, pp.172017-2025, 2006.
DOI : 10.1681/ASN.2005101051

E. Goicoechea-de-jorge, C. Harris, J. Esparza-gordillo, L. Carreras, E. Arranz et al., Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome, Proceedings of the National Academy of Sciences, vol.104, issue.1, pp.240-245
DOI : 10.1073/pnas.0603420103

D. Kavanagh, E. Kemp, E. Mayland, R. Winney, J. Duffield et al., Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome, Journal of the American Society of Nephrology, vol.16, issue.7, pp.162150-2155, 2005.
DOI : 10.1681/ASN.2005010103

D. Kavanagh, E. Kemp, A. Richards, R. Burgess, E. Mayland et al., Does complement factor B have a role in the pathogenesis of atypical HUS?, Molecular Immunology, vol.43, issue.7, pp.43856-859, 2006.
DOI : 10.1016/j.molimm.2005.06.041

D. Serres, S. Isenring, and P. , Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria, Nephrology Dialysis Transplantation, vol.24, issue.3, pp.1048-1050, 2009.
DOI : 10.1093/ndt/gfn687

A. Veyradier, B. Obert, A. Houllier, D. Meyer, and J. Girma, Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, vol.98, issue.6, pp.981765-1772, 2001.
DOI : 10.1182/blood.V98.6.1765

A. Sellier-leclerc, V. Fremeaux-bacchi, M. Dragon-durey, M. Macher, P. Niaudet et al., Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome, Journal of the American Society of Nephrology, vol.18, issue.8, pp.182392-2400, 2007.
DOI : 10.1681/ASN.2006080811

URL : https://hal.archives-ouvertes.fr/inserm-00409786

F. Fakhouri, L. Roumenina, F. Provot, M. Sallee, S. Caillard et al., Pregnancy-Associated Hemolytic Uremic Syndrome Revisited in the Era of Complement Gene Mutations, Journal of the American Society of Nephrology, vol.21, issue.5, pp.859-867, 2010.
DOI : 10.1681/ASN.2009070706

URL : https://hal.archives-ouvertes.fr/hal-00512540

E. Dorresteijn, N. Van-de-kar, and K. Cransberg, Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count, Pediatric Nephrology, vol.22, issue.7, pp.1193-1195
DOI : 10.1007/s00467-012-2130-z

J. George, D. Terrell, K. Swisher, and S. Vesely, Lessons learned from the Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry, Journal of Clinical Apheresis, vol.110, issue.4, pp.129-137, 2008.
DOI : 10.1002/jca.20169

S. Vesely, J. George, B. Lammle, J. Studt, L. Alberio et al., ADAMTS13 activity in thrombotic thrombocytopenic purpura--hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients, Blood, vol.102, issue.1, pp.60-68, 2003.
DOI : 10.1182/blood-2003-01-0193